WallStreetZenWallStreetZen

NASDAQ: ACAD
Acadia Pharmaceuticals Inc Stock Ownership - Who owns Acadia Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Acadia Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2025-08-1822,000$25.18
$554.03kSell
Laura BregeDirector2025-06-0414,446$21.78
$314.63kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2025-05-162,000$20.00
$40.00kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2025-05-162,000$25.00
$50.00kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2025-05-162,000$25.00
$50.00kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2025-05-021,327$14.60
$19.37kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2025-05-023,498$14.60
$51.07kSell
Mark C. SchneyerEVP CHIEF FINANCIAL OFFICER2025-04-082,708$14.82
$40.13kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2025-04-081,028$14.82
$15.23kSell
James KiharaPRINCIPAL ACCOUNTING OFFICER2025-03-261,095$17.05
$18.67kSell

1 of 2

ACAD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACAD insiders and whales buy or sell their stock.

ACAD Shareholders

What type of owners hold Acadia Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP25.63%42,896,690$1.06BInstitution
Baker Bros Advisors LP23.58%39,468,841$978.24MInsider
Blackrock Inc12.34%20,652,416$511.87MInstitution
Vanguard Group Inc9.12%15,264,240$378.32MInstitution
Baker Brothers Life Sciences LP8.50%14,229,612$352.68MInsider
Rtw Investments LP5.37%8,995,547$222.95MInstitution
State Street Corp3.69%6,178,044$153.12MInstitution
Morgan Stanley2.46%4,111,247$101.90MInstitution
Point72 Asset Management LP1.90%3,172,511$78.63MInstitution
Oxford Bioscience Partners IV LP1.89%3,160,238$78.33MInsider

1 of 3

ACAD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACAD72.40%27.60%Net SellingNet Selling
KRYS78.73%21.27%Net SellingNet Selling
ADMA78.76%21.24%Net SellingNet Selling
PCVX88.04%11.96%Net Selling
AAPG0.02%0.00%
View Top Biotech Stocks

Acadia Pharmaceuticals Stock Ownership FAQ

Who owns Acadia Pharmaceuticals?

Acadia Pharmaceuticals (NASDAQ: ACAD) is owned by 101.27% institutional shareholders, 38.60% Acadia Pharmaceuticals insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Acadia Pharmaceuticals shareholder, owning 39.47M shares representing 23.58% of the company. Baker Bros Advisors LP's Acadia Pharmaceuticals shares are currently valued at $1.02B.

If you're new to stock investing, here's how to buy Acadia Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.